Purpose: We tested the performance and clinical applicability of combined protocols for brain imaging studies acquired on a new whole-body hybrid PET/ MR scanner. Patients and Methods: Fifteen patients [6 male and 9 female patients; mean (SD) age, 51 (30) y; range, 6Y89 y] were scanned on a Philips Ingenuity TF PET/MR. Standard imaging protocols of both modalities were combined, using a ''head coil'' and contrast-enhanced fully diagnostic MR protocols. Attenuation correction of the PET images was performed using tissue segmentation of the MR image and incorporation of attenuation templates measured for coils and table.
H ybrid PET/MR is a recently developed technique that is gaining a growing interest from the medical community owing to its potential clinical applications. 1Y5 PET and MR are the methods of choice for neuroimaging, allowing to combine the metabolic information (glucose metabolism for various functional investigations, amino acid metabolism for tumor detection) provided by PET imaging, with the various morphological and functional parameters measured by MR.
In this respect, MR has clear advantages compared to CT and mainly to the nonYcontrast-enhanced CT, which is usually coupled to PET when a routine PET/CT investigation is realized. There are already preliminary reports describing the potential clinical applications of hybrid PET/MR in brain imaging based on studies realized on a brain-dedicated prototype of hybrid PET/MR. 6, 7 However, dedicated brain systems usually have limited availability, mainly confined to research centers. New whole-body PET/MR hybrid scanners that are currently available will presumably have a wider diffusion over the next few years, being able to perform both brain and whole-body imaging.
The aim of this study was to test the implementation of a new whole-body hybrid PET/MR sequential scanner when realizing brain studies in clinical routine. The specifications and performance characteristics of the Philips Ingenuity time-of-flight PET/MR have been described in detail elsewhere. 8 Some recent publications reported on the use of this tomograph for whole-body applications, 9Y11 in 1 case of stroke and crossed cerebellar diaschisis, 12 and for investigating peripheral nerve involvement. 13 In this work, we focused on 3 main referral indications, for which both PET and MR are routinely performed: cognitive impairment of probable neurodegenerative origin, presurgical evaluation of drug-refractory epilepsy, and brain tumor staging.
PATIENTS AND METHODS

Patient Population
Fifteen patients [6 male and 9 female patients; mean (SD) age, 51 (30) y; range, 6Y89 y] were scanned on a Philips Ingenuity TF PET/MR (Geneva University Hospitals, Geneva, Switzerland). This device consists of the 2 separate scanners (the Ingenuity Time-of-Flight PET scanner and an Achieva 3T X-series MRI) linked through a single patient table, allowing for sequential imaging. Standard imaging protocols for both modalities were applied. This study was approved by the ethical committee of the Geneva University Hospital.
Imaging Protocols
PET/MR studies consisted of diagnostic sequences using standard MR protocols corresponding to different clinical indications, a dedicated MR sequence acquired for PET attenuation correction (T1-weighted image fast-field echo termed atMR), and a 3-dimensional (3D) PET data acquisition.
The default atMR acquisition protocol consisted of an MR sequence suitable for deriving an attenuation map. The atMR images were converted to an attenuation map using the 3-segment algorithm, as described previously. 8 This map was used to correct PET images for attenuation using average tissue attenuation properties in contrast to CT-based attenuation correction implemented on commercial PET/CT scanners. Templates for the bed and the RF coils were added to the patient's attenuation map.
Depending on the clinical indication, the clinical MR part of the examination included T1-weighted and T2-weighted turbo-spin-echo sequences (T1w SE and T2w TSE), T2-weighted gradient echo sequences (T2w GE), 3D fluid-attenuated inversion recovery (FLAIR), gradient echo T2 or susceptibility-weighted imaging (SWI), perfusion and diffusion tensor imaging (DTI), and arterial spin labeling (ASL; Table 1 ).
A 15-minute 18 F-FDG PET acquisition was performed 30 minutes after IV injection of 250 MBq of the tracer.
For the investigation of neurodegenerative disorders, the uptake phase was done in a dimly lit room, with the patient lying quiet, to avoid any interference with the distribution of the tracer.
For epileptic focus localization, a list mode acquisition for 45 minutes starting with the tracer injection was preferred to estimate absolute quantitative glucose metabolism using the Patlak noninvasive analysis (data not shown): the clinical interpretation, however, was based on the last 15 minutes of the acquisition, reconstructed as a static image. The results presented in this work are based on these data. The F-fluoroethyltyrosine (FET) PET imaging was acquired 30 minutes after injection of 200 MBq of the tracer: the uptake phase was done on the PET/MR tomograph and was used for acquiring MR sequences to shorten the total scanning duration.
The injected activity was adapted according to the body weight for the pediatric cases, following the European Association of Nuclear Medicine guidelines.
14 Each case was interpreted by a multidisciplinary team of nuclear physicians, radiologists, and neurologists.
RESULTS
Scan Time
The duration of the T1w fast-field echo sequence for attenuation correction was 1 min 20 s. The mean (SD) duration of total diagnostic MR examination was 36 (22) minutes (range, 10Y72 minutes). The PET duration was 10Y15Y45 minutes depending on the clinical indication (Table 1) .
We used standard clinical MR and PET protocols; therefore, the duration of the examination was identical to the sum of 2 separate examination. However, the positioning, which usually takes between 3 and 10 minutes in our experience, depending on patient's compliance, was done only once, in comparison to examinations performed on 2 separate scanners.
PET and MR Image Quality
All acquired MR data sets provided diagnostic image quality (examples are provided in the figures). Magnetic susceptibility artifacts appeared in 2 cases due to an implant (ventriculoperitoneal drain for patients 14 and 15), very limited and with no impact on image interpretation. Motion artifacts were visible in 2 cases (patients 10 and 15).
Uncorrected PET data sets showed optimal image quality. Corrected PET images, using the TOF technology, allowed reconstructing high-resolution images (slice thickness, 2 mm), ideal for depicting medial temporal lobe alterations (an example is provided in Fig. 1 ).
It should be noted that attenuation correction could introduce some bias associated with motion artifacts; however, these could be corrected by coregistration of the atMR with the PET image followed by subsequent offline reconstruction (Fig. 2) . 
Diagnostic Performance
The results obtained in individual cases are summarized in Table 2 . 
Pathological PET and MR Findings
Twelve subjects had pathological findings, shown in detail in Table 2 .
In 11 of the 12 cases, the PET/MR positive findings were confirmed as true-positive by clinical follow-up. For the remaining case, patient 15, PET and MR findings were suspicious for a tumor recurrence; however, the lesions had a favorable morphological evolution over time, with almost complete regression over a year. This evolution revealed that the lesion was in fact a radiation necrosis.
Normal PET and MR Studies
Three subjects had no pathological findings: for all 3, the clinical follow-up so far confirmed the initial imaging results.
In particular, for 2 cases (patients 8 and 9), a diagnosis of possible generalized epilepsy was retained. For patient 14, the clinical and imaging follow-up did not show any sign of tumor progression: for this reason, given that the images showed the surgical sequelae, but no new pathological finding, we classified this study among the ''normal'' studies.
DISCUSSION
This report demonstrates the feasibility of PET/MRI of the brain using a new whole-body PET/MR hybrid tomograph in a clinical setting.
Hybrid PET/MR is a recently developed technique, available on the market since approximately a year. The design of currently available systems reflects different solutions to solve the major challenges that rise when bringing these 2 technologies together. 15 First, for PET detectors to be compatible with MR magnetic field, photomultiplier technology must be replaced with magnetic fieldY insensitive avalanche photodiodes or silicon photomultipliers. 16, 17 Alternatively, sequential imaging and proper shielding have been used. 4, 5 The system used in this work uses sequential imaging, allowing performing a fully diagnostic MR protocol with dedicated coils, equivalent to the standalone Achieva MR system. For brain imaging, PET and MR are the methods of choice for clinical investigations and are currently performed systematically for all patients in 2 imaging sessions.
In our experience, with respect to the 3 main referral indications, that is, clinical suspicion of neurodegenerative dementia, epilepsy, and brain tumors, we had overall satisfactory results, obtaining all information that would normally be obtained with 2 separate examinations.
The main advantage associated with the hybrid technology is the fact that all relevant imaging information can be collected in 1 single session.
In addition, while a PET/MR study is longer than a standard diagnostic PET/CT study, it is still shorter than the total time that a PET/CT and an MR study would take today when performed on 2 separate scanners at different times.
This could be achieved by optimizing the MR protocol and by having to position the patient only once. This second issue is particularly important for patients with limited compliance, having some degree of executive and motor impairment, as might be often the case for patients investigated for neurodegenerative disorders or brain lesions.
In addition, the single imaging session, as compared with 2 separate sessions, is more comfortable for the patients and the caregivers, and it is especially important when additional procedures, such as anesthesia or sedation, are required.
This clearly benefits the patients that need both PET-CT and MR studies in their clinical workup, such as patients with neurological disorders.
Furthermore, this assures also that the patient's conditions are the same for the 2 studies, in particular with respect to disease progression, or with the effect of medications. This is not necessarily the case for a PET and an MR realized separately, which are often some days if not weeks apart.
Another factor that favors MR over CT for hybrid imaging devices is the reduction in radiation exposure, eliminating additional radiation dose to the patient owing to the use of ionizing radiation in CT (ranging between 220 and 450 KSv for a high-quality scan 18 ). The effective dose associated with the FDG and FET activity we administer is 4.75 and 3.3 mSv, respectively, in adults 18, 19 ; therefore, a high-quality brain CT scan might represent up to 12% of the total dose.
The reduced radiation exposure of PET/MR compared with PET/CT is of special interest in the pediatric population. 20, 21 We might also expect that PETand MR information are not only combined, but that there is an additional value owing to the cointerpretation of the 2 signals: encouraging multidisciplinary interpretation of the results is, in our experience, an added value to fully diagnostic hybrid imaging. In addition, the integration of MR parameters, such as regional perfusion, into the analysis of PET parameters, such as SUVand distribution volumes, may provide additional information.
In particular, concerning degenerative syndromes, we could observe a superior specificity of MR for vascular lesions (as for patient 1) and a superior specificity of PET metabolic patterns for Lewy body dementia and frontotemporal dementia (as found in patients 2, 3, and 4). This is consistent with literature data. 22, 23 For epilepsy, the fusion of morphological and functional information allowed identifying subtle metabolic alterations, which could easily be missed when interpreting the FDG images alone, as depicted in Figure 3 : this observation is in line with previous reports showing the added value of software fusion for PET and MR data for the presurgical investigation of cortical dysplasias. 24, 25 This study also shows some limitations of the hybrid PET/MR modality for brain studies.
First, the long examination duration might involve patient movement and motion artifacts. This aspect might further stimulate the research of fully hybrid solutions with simultaneous imaging. In our study, we observed significant motion in 2 of 15 subjects, which we managed to correct manually to obtain a satisfactory image fusion and attenuation correction. We limited the total examination duration by acquiring diagnostic MR images during the FET uptake phase. Further experience and research will also be needed to identify if certain MR sequences are redundant when the molecular information provided by PET is available.
Second, the quantification issue, with respect to MR-guided attenuation correction, still needs further validation. This might be critical for neuroreceptor studies where absolute quantification is needed, and differences between healthy subjects and patient populations are often subtle. In this respect, ongoing studies, also by our group, are focusing on the validation of MR versus CT-based attenuation correction. 26 For this reason, we focused our clinical practice with this new modality on studies whose interpretation was mostly based on qualitative or semiquantitative PET assessment, rather than quantitative measures.
CONCLUSIONS
The possibility to combine PET with a large variety of MR sequences opens new horizons for bimodal multiparametric imaging of the human brain. Acquiring both PET and MR in a single session on a hybrid tomograph minimized patient discomfort while maximizing clinical information and optimizing registration of both modalities.
Simplification of imaging protocols allowed keeping the total duration of the examination within a tolerable range (G2 hours), with an important impact on MR image quality.
In addition, in comparison to PET/CT, the effective dose (CT related) could be reduced, and this is particularly beneficial in the pediatric population.
